Vitaliy Volansky, DPM
Foot Surgery · Boston, MANPI 1679703151
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,079 of the $1,415 with a category attached, or 76.2%. 12 manufacturers reported payments, led by Integra Lifesciences Corporation at 32.7% of the total. Reporting peaked in 2024 at $550 and has fallen 75.4% since, to $135 in 2025.
Across 19 payments — averaging $74.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$463
- Acera Surgical, Inc.$222
- Mimedx Group, Inc.$166
- Kairos Surgical Inc$136
- Stryker$129
- Zimmer Biomet$102
- plus $197 from 6 others
Across 44 payments — averaging $8890.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biotissue Holdings Inc.$149K
- Convatec Inc.$137K
- Acera Surgical, Inc.$78K
- Reddress LTD$26K
What the payments were for
- Food & beverage$1,07976%
- Other$33724%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 4 | $463 |
| Acera Surgical, Inc. | 2 | $222 |
| Mimedx Group, Inc. | 2 | $166 |
| Kairos Surgical Inc | 1 | $136 |
| Stryker | 3 | $129 |
| Zimmer Biomet | 1 | $102 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $100 |
| Bone Support Inc. | 1 | $26 |
| Kerecis Limited | 1 | $22 |
| Smith+Nephew | 1 | $18 |
| Orthofix Medical, Inc. | 1 | $16 |
| Medtronic | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$337
- Restrata Wound Matrix$126
- STAR$107
- TAPESTRY$102
How this compares
$1,415 in reported general payments places this provider in the 70th percentile of 41 foot surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 126 | $5,030 |
| Econazole Nitrate | 40 | $1,383 |
| Ciclopirox | 49 | $1,021 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 52 | $855 |
| Ammonium Lactate | 54 | $641 |
| Ketoconazole | 19 | $561 |
| Tramadol Hcl | 19 | $54 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Boston
- Adam LandsmanBoston$385K
- Christopher LockeBoston$6K
- Justin OgbonnaBoston$4K
- Wei TsengBoston$3K
- Jordana SzpiroBoston$734
- Mark RoseNatick$9K
- Jamey AllenWoburn$8K
- Ewald MendeszoonWest Roxbury$6K
- Jurgen FernandezLynn$4K
- Neil FeldmanWorcester$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.